VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)

Pharmacological Reviews

Volumn 46, Issue 2, 1994, Pages 157-203

  Hoyer, Daniel ^a   Clarke, David E ^b   Fozard, John R ^a   Hartig, Paul R ^c   Martin, Graeme R ^d   Mylecharane, Ewan J ^e   Saxena, Pramod R ^f   Humphrey, Patrick P A ^g  

^a Sandoz Pharma Ltd   (Switzerland)

^b ROCHE BIOSCIENCE   (United States)

^c DUPONT COMPANY   (United States)

^d WELLCOME RESEARCH LABORATORIES   (United Kingdom)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 METHYLSEROTONIN; 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA METHYLSEROTONIN; BUSPIRONE; CARPINDOLOL; CINANSERIN; GRANISETRON; IPSAPIRONE; ISAMOLTANE; KETANSERIN; MECOPROP; MESULERGINE; METERGOLINE; METHYSERGIDE; METITEPINE; METOCLOPRAMIDE; ONDANSETRON; PINDOLOL; PIRENPERONE; RAUWOLSCINE; RECEPTOR SUBTYPE; RENZAPRIDE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN; TROPISETRON; UNINDEXED DRUG; YOHIMBINE; LIGAND;

DRUG RECEPTOR BINDING; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE DISTRIBUTION; ANIMAL; BRAIN; CLASSIFICATION; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMAL; BRAIN; HUMAN; LIGANDS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION;

EID: 0028183017     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (511)

1. 1F receptor to multiple signal transduction pathways. Naunyn Schmiedebergs Arch. Pharmacol. 348: 566-575, 1993b.
2. 1 receptor subtype coupled to the inhibition of adenylyl cyclase. Proc. Natl. Acad. Sci. USA 90: 408-412, 1993a.
3. 1Dβ receptor. Mol. Pharmacol. 41: 1-7, 1992.
4. ADLER-GRASCHINSKY, E., ELGOYHEN, A. B., AND BUTTA, N. V.: Different receptor subtypes mediate the dual presynaptic effects of 5-hydroxytryptamine on peripheral sympathetic neurones. J. Auton. Pharmacol. 9: 3-13, 1989.
5. AHLQUIST, R. P.: A study of the adrenergic receptors. Am. J. Physiol. 153: 586-600, 1948.
6. 1A receptor gene. J. Biol. Chem. 265: 5825-5832, 1990.
7. 1E-like serotonin receptor expressed predominantly in hippocampus. J. Biol. Chem. 267: 19761-19764, 1992.
8. 4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J. Pharmacol. Exp. Ther. 257: 930-937, 1991a.
9. ANDRADE, R., AND CHAPUT, Y.: The electrophysiology of serotonin receptor subtypes. In Serotonin Receptor Subtypes: Basic and Clinical Aspects, edited by S. J. Peroutka, pp. 103-124, Wiley-Liss Inc., New York, 1991b.
10. 8 receptors to the same channels in hippocampus. Science 234: 1261-1265, 1986.
11. ANDREWS, P. L. R., AND BHANDARI, P.: The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action. Eur. J. Cancer 29A (Suppl. 1): S11-S16, 1993.
12. ANDREWS, P. L. R., RAPEPORT, W. G., AND SANGER, G. J.: Neuropharmacology of emesis induced by anticancer therapy. Trends Pharmacol. Sci. 9: 334-341, 1988.
13. 4 receptor desensitization in colliculi neurones. Mol. Pharmacol. 42: 808-816, 1992.
14. APPERLEY, E., FENIUK, W., HUMPHREY, P. P. A., AND LEVY, G. P.: Evidence for two types of excitatory receptors for 5-hydroxytryptamine in dog isolated vasculature. Br. J. Pharmacol. 68: 215-222, 1980.
15. AZAMI, J., FOZARD, J. R., ROUND, A. A., AND WALLIS, D. I.: The depolarising action of 5-hydroxytryptamine on rabbit vagal primary afferent and sympathetic neurones and its selective blockade by MDL 72222. Naunyn Schmiedebergs Arch. Pharmacol. 328: 423-429, 1985.
16. 1D-like receptor. J. Recept. Res. 13: 479-502, 1993.
17. (1C) receptor. Mol. Pharmacol. 38: 31-37, 1990.
18. 7) positively linked to adenylyl cyclase. J. Biol. Chem. 268: 23422-23426, 1993.
19. 3 receptor ligands. Neurosci. Biobehav. Rev. 16: 107-113, 1992a.
20. BARNES, N. M., CHENG, C. H. K., COSTALL, B., GE, J., AND NAYLOR, R. J.: Differential modulations of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride. Br. J. Pharmacol. 107: 233-239, 1992b.
21. BAX, W. A., RENZENBRINK, G. J., VAN HEUVEN-NOLSEN, D., THIJSSEN, E. J. M., BOS, E., AND SAXENA, P. R.: 5-HT receptors mediating contractions of the isolated human coronary artery. Eur. J. Pharmacol., 239: 203-210, 1993.
22. 1D-like receptors, and a comparison with 'grafted' veins. Naunyn Schmiedebergs Arch. Pharmacol. 345: 500-508, 1992.
23. 4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn Schmiedebergs Arch. Pharmacol. 343: 439-446, 1991a.
24. BAXTER, G. S., PRITIKIN, J., YOUNG, H., AND CLARKE, D. E.: 5-HT receptors in human ileum and colon. Br. J. Pharmacol. 102: 163P, 1991b.
25. 1Dβ receptor subtype in human cortex. Eur. J. Pharmacol. 242: 195-198, 1993.
26. 1D receptor binding affinity of 5-hydroxytryptamine, 5-carboxamidotryptamine and sumatriptan in the central nervous system of seven species. Eur. J. Pharmacol. 213: 193-197, 1992.
27. 1D receptor agonist. Br. J. Pharmacol., 110: 1196-1200, 1993.
28. 1B receptor mediation. Eur. J. Pharmacol. 135: 279-287, 1987.
29. 1A receptor in Escherichia coli. J. Biol. Chem. 267: 8200-8206, 1992.
30. 4 receptor in zacopride- and copper sulfate-induced vomiting in the ferret. Eur. J. Pharmacol. 204: 273-280, 1991.
31. BIEGER, D., AND TRIGGLE, C.: Pharmacological properties of mechanical responses of the rat oesophageal muscularis mucosae to vagal and field stimulation. Br. J. Pharmacol. 84: 93-106, 1985.
32. 1A receptor antagonist, WAY 100135. Br. J. Pharmacol. 108: 94P, 1993.
33. BLACK, J. W.: Should we be concerned about the state of hormone receptor classification? In Perspectives on Receptor Classification, edited by J. W. Black, D. H. Jenkinson, and P. Gerskowitz, pp. 11-15, Alan R. Liss Inc., New York, 1987.
34. 2-receptors. Nature (Lond.) 236: 385-390, 1972.
35. BLANDINA, P., GOLDFARB, J., CRADDOCK-ROYAL, B., AND GREEN, J. P.: Release of endogenous dopamine by stimulation of 5-hydroxytryptamine receptors in rat striatum. J. Pharmacol. Exp. Ther. 251: 803-809, 1989.
36. 3 receptor antagonist ICS 205930. Life Sci. 43: 1441-1449, 1988.
37. 1A receptors negatively coupled with adenylate cyclase in hippocampal neurones. Naunyn Schmiedebergs Arch. Pharmacol. 325: 588-592, 1987.
38. 4 receptors: relationship between the effects of indole, benzamide and azabicycloalkybenzimidazolone derivatives. In Serotonin, Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 220-231, Birkhauser Verlag, Basel, Switzerland, 1991.
39. 4 receptor: a place in the sun. Trends Pharmacol. Sci., 13: 141-145, 1992.
40. 4) receptors positively coupled to adenylate cyclase in adult guinea-pig hippocampal membranes: effect of substituted benzamide derivatives. Mol. Pharmacol. 37: 408-411, 1990.
41. BODDEKE, H. W. G. M., AND KALKMAN, H. O.: Zacopride and BRL 24924 induce an increase in EEG-energy in rats. Br. J. Pharmacol. 101: 281-284, 1990.
42. 4 receptors in rat hippocampus by R(+)- and S(-)-zacopride: no evidence for stereo-selectivity. Neurosci. Lett. 134: 261-263, 1992.
43. 1A receptors: studies in transfected HeLa cells. Naunyn Schmiedebergs Arch. Pharmacol. 345: 257-263, 1992.
44. 1c receptor. J. Pharmacol. Exp. Ther. 264: 709-716, 1993.
45. BOECKXSTAENS, G. E., PELCKMANS, P. A., RAMPART, M., BOGERS, J. J., VERBEUREN, T. J., HERMAN, A. G., AND VAN MAERCKE, Y. M.: Pharmacological characterisation of 5-hydroxytryptamine receptors in the canine terminal ileum and ileocolonic junction. J. Pharmacol. Exp. Ther. 254: 652-658, 1990.
46. BOM, A. H., DUNCKER, D. J., SAXENA, P. R., AND VERDOUW, P. D.: 5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor. Br. J. Pharmacol., 93: 663-671, 1988.
47. 1B, subtype. Eur. J. Pharmacol. 171: 87-96, 1989.
48. 3H]RS-42358-197: evidence for receptor heterogeneity. J. Neurochem. 61: 1927-1932, 1993.
49. BORTON, M., NELIGAN, M., WOOD, F., DERVAN, P., GOGGINS, K., AND DOCHERTY, J. R.: Contractions to 5-hydroxytryptamine in human coronary artery and human saphenous vein. Br. J. Clin. Pharmacol. 30 (Suppl. 1): 107S-108S, 1990.
50. 1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra. Eur. J. Pharmacol. 151: 189-196, 1988.
51. 1D binding sites. J. Neurochem. 58: 951-959, 1992.
52. BRADLEY, P. B., ENGEL, G., FENIUK, W., FOZARD, J. R., HUMPHREY, P. P. A., MIDDLEMISS, D. N., MYLECHARANE, E. J., RICHARDSON, B. P., AND SAXENA, P. R.: Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563-576, 1986a.
53. 2 type, mediating contraction of rabbit isolated basilar artery. Br. J. Pharmacol 87: 3-4, 1986b.
54. 2 receptor. Mol. Pharmacol. 38: 604-609, 1990.
55. BRANCHER, T. A., KATES, M., AND GERSHON, M. D.: Enteric receptors for 5-hydroxytryptamine. Brain Res. 324: 107-118, 1984.
56. 3H-5-hydroxyindalpine. J. Neurosci. 8: 2582-2595, 1988.
57. 1D receptor. In Serotonin, Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 21-32, Birkhauser Verlag, Basel, Switzerland, 1991.
58. BREWERTON, T. D., MURPHY, D. L., MUELLER, E. A., AND JIMERSON, D. C.: Induction of migraine-like headaches by the serotonin agonist m-chlorophenylpiperazine. Clin. Pharmacol. Therap. 43: 605-609, 1988.
59. BRITTAIN, R. T., JACK, D., AND RICHIE, A. C.: Recent β-adrenoreceptor stimulants. Adv. Drug Res. 5: 197-253, 1970.
60. 4 receptors. Br. J. Pharmacol., 110: 10P, 1993.
61. 1B receptor messenger RNA in rat brain and trigeminal ganglia. Br. J. Pharmacol., 108: 95P, 1993b.
62. 1D recognition sites in the human substantia nigra identified with a new iodinated radioligand. Eur. J. Pharmacol. 202: 89-91, 1991.
63. 1D binding sites in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 347: 569-582, 1993a.
64. 4 receptors. Eur. J. Pharmacol. 205: 203-208, 1991.
65. 1C receptors. Br. J. Pharmacol. 88: 367P, 1986.
66. 4 receptors in the isolated guinea-pig ileum. Eur. J. Pharmacol. 200: 373-374, 1991.
67. 4 receptors in the isolated guinea-pig ileum. Naunyn Schmiedebergs Arch. Pharmacol. 354: 387-393, 1992.
68. BUNCE, K. T., ELSWOOD, C. J., AND BALL, M. T.: Investigation of the 5-hydroxytryptamine receptor mechanism mediating the short-circuit current response in rat colon. Br. J. Pharmacol. 102: 811-816, 1991.
69. 3 receptors in three isolated preparations derived from guinea-pig tissues. Br. J. Pharmacol. 101: 591-598, 1990.
70. 3 receptors. Br. J. Pharmacol. 94: 397-412, 1988.
71. BUZZI, M. G., CARTER, W. B., SHIMIZU, T., HEATH, H., AND MOSKOWITZ, M. A.: Dihydroergotamine and sumatriptan attenuate the increase in plasma CGRP levels within rat superior sagittal sinus during electrical trigeminal ganglion stimulation. Neuropharmacology 5: 5-18, 1991a.
72. BUZZI, M. G., AND MOSROWITZ, M. A.: The antimigraine drug sumatriptan GR 43175 selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmacol. 99: 202-206, 1990.
73. BUZZI, M. G., MOSKOWITZ, M. A., PEROUTKA, S. J., AND BYUN, B.: Further characterisation of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasion in rat dura mater. Br. J. Pharmacol. 103: 1421-1428, 1991b.
74. CADOGAN, A., AND HUMPHREY, P. P. A.: Classification of the 5-HT receptor mediating cardio-excitation in the snail, Helix aspersa. Br. J. Pharmacol. 102: 97P, 1991.
75. CAMBRIDGE, D., WHITING, M. V., AND BUTTERFIELD, L. J.: 5-Carboxamidotryptamine induced renal vasoconstriction in the dog. In Serotonin: Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 282-288, Birkhauser Verlag, Basel, Switzerland, 1991.
76. 1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphé dorsalis. Eur. J. Pharmacol. 158: 53-59, 1988.
77. 1-like receptors in guinea-pig basilar arteries. Acta Physiol. Scand. 136: 59-67, 1989.
78. CHAPUT, Y., ARANEDA, R. C., AND ANDRADE, R.: Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus. Eur. J. Pharmacol. 182: 441-456, 1990.
79. 1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes. Naunyn Schmiedebergs Arch. Pharmacol. 332: 8-15, 1986.
80. CHENG, C. H. K., BARNES, N. M., COSTALL, B., GE, J., AND NAYLOR, R. J.: Differential activities of (R)- and (S)-zacopride to modify extracellular levels of 5-HT in the rat frontal cortex. Br. J. Pharmacol. 105: 36P, 1992.
81. CHESTER, A. H., MARTIN, G. R., BODELSSON, M., ARNEKLO-NOBIN, B., TADJKARIMI, S., TÖRNEBRANDT, K., AND YACOUB, M. H.: 5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc. Res. 24: 932-937, 1990.
82. 1B receptors in brain. J. Pharmacol. Exp. Ther. 252: 1347-1354, 1990.
83. 4 receptor: current status. In Serotonin: from Cell Biology to Pharmacology and Therapeutics, edited by P. M. Vanhoutte, P. R. Saxena, R. Paoletti, and N. Brunello, pp. 107-117, Kluwer Academic Publishers and Fondazione Giovanni Lorenzini, Dordrecht, The Netherlands, 1993.
84. CLARKE, D. E., BOND, R. A., CHARLTON, K. G., AND BLUE, D. R.: Pre-synaptic 5-HT receptors mediating inhibition of transmitter release from peripheral cholinergic and noradrenergic nerves. In Serotonin: Actions, Receptors, Pathophysiology, edited by E. J. Mylecharane, J. A. Angus, I. S. de la Lande, and P. P. A. Humphrey, pp. 48-55, Macmillan Press, Basingstoke, UK, 1989b.
85. 4 receptor: naughty but nice. Trends Pharmacol. Sci. 10: 385-386, 1989a.
86. 1A receptor agonists inhibit carbachol-induced stimulation of phosphoinositide turnover in the rat hippocampus. Eur. J. Pharmacol. 149: 149-153, 1989.
87. 1C receptors (Abstr. 23). Presented at the Second IUPHAR Satellite Meeting on Serotonin, Basel, Switzerland, July 11-13, 1990.
88. CLINESCHMIDT, B. V., REISS, D. R., PETTIBONE, D. J., AND ROBINSON, J. L.: Characterisation of 5-hydroxytryptamine receptors in rat stomach fundus. J. Pharmacol. Exp. Ther. 235: 696-708, 1985.
89. COCKS, T. M., AND ANGUS, J. A.: Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature (Lond.) 305: 627-630, 1983.
90. 4 receptors. Br. J. Pharmacol. 107: 591-596, 1992.
91. COHEN, M. L.: 5-Hydroxytryptamine and non-vascular smooth muscle contraction and relaxation. In The Peripheral Actions of 5-Hydroxytryptamine, edited by J. R. Fozard, pp. 201-218, Oxford University Press, Oxford, UK, 1989.
92. 1D receptor ligands in canine saphenous veins. Eur. J. Pharmacol. 211: 43-46, 1992.
93. COHEN, M. L., AND WITTENAUER, L. A.: Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular and tracheal smooth muscle. J. Cardiovasc. Pharmacol. 10: 176-181, 1987.
94. COLEMAN, R. A., AND HUMPHREY, P. P. A.: Prostaglandins-receptors and mode of action. In Clinical Application of Prostaglandins, edited by J. R. Vane and J. O'Grady, pp. 15-36, Edward Arnold Publishers Ltd., Seven Oaks, England, 1993.
95. 2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology 23: 993-996, 1984.
96. CONN, P. J., AND SANDERS-BUSH, E.: Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions. J. Pharmacol. Exp. Ther. 234: 195-203, 1985.
97. CONN, P. J., AND SANDERS-BUSH, E.: Agonist-induced phosphoinositide hydrolysis in choroid plexus. J. Neurochem. 47: 1754-1760, 1986.
98. CONN, P. J., SANDERS-BUSH, E., HOFFMAN, B. J., AND HARTIG, P. R.: A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc. Natl. Acad. Sci. USA 83: 4086-4088, 1986.
99. CONNELL, L. A., AND WALLIS, D. I.: Responses to 5-hydroxytryptamine evoked in the hemisected spinal cord of the neonate rat. Br. J. Pharmacol. 94: 1101-1114, 1988.
100. CONNELL, L. A., AND WALLIS, D. I.: 5-Hydroxytryptamine depolarises neonatal rat motoneurones through a receptor unrelated to an identified binding site. Neuropharmacology 28: 625-634, 1989.
101. CONNER, D. A., AND MANSOUR, T. E.: Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor. Mol. Pharmacol. 37: 742-751, 1990.
102. 2 receptor activation. Eur. J. Pharmacol. 161: 91-94, 1989a.
103. 1-like receptor agonist. Br. J. Pharmacol. 96: 379-387, 1989b.
104. CONNOR, H. E., FENIUK, W., HUMPHREY, P. P. A., AND PERREN, M. J.: 5-Carboxamidotryptarmne is a selective agonist at 5-hydroxytryptamine receptors mediating vasodilatation and tachycardia in anaesthetised cats. Br. J. Pharmacol. 87: 417-426, 1986.
105. CONNOR, H. E., HUMPHREY, P. P. A., AND FENIUK, W.: Serotonin receptors - therapeutic prospects in cardiovascular disease. Trends Cardiovasc. Med. 1: 205-210, 1991.
106. 1-like receptor agonist, on pial vessel diameter in anaesthetized cats. J. Cereb. Blood Flow Metab. 12: 514-519, 1992.
107. (1A) receptor negatively linked to adenylate cyclase. Eur. J. Pharmacol. 173: 189-192, 1989.
108. CORSI, M., PIETRA, C., TOSON, G., TRIST, D., TUCCITTO, G., AND ARTIBANI, W.: Pharmacological analysis of 5-hydroxvtryptamine effects on electrically stimulated human isolated urinary bladder. Br. J. Pharmacol. 104: 719-725, 1991.
109. CORTÉS, R., PALACIOS, J. M., AND PAZOS, A.: Visualisation of multiple serotonin receptors in the rat brain by autoradiography. Br. J. Pharmacol. 82: 202P, 1984.
110. 3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse. Br. J. Pharmacol. 96: 325-332, 1989.
111. COSTALL, B., AND NAYLOR, R. J.: 5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders. Scand. J. Gastroenterol. 25: 769-787, 1990.
112. CRAIG, D. A., AND CLARKE, D. E.: 5-Hydroxytryptamine and cholinergic mechanisms in guinea-pig ileum. Br. J. Pharmacol. 96: 246P, 1989.
113. 4 receptor. J. Pharmacol. Exp. Ther. 252: 1378-1386, 1990.
114. 4 receptor activation. Br. J. Pharmacol. 102: 563-564, 1991.
115. 4 receptors in guinea-pig ileum. Naunyn Schmiedebergs Arch. Pharmacol. 342: 9-16, 1990.
116. 1B receptors mediate potent contractile responses to 5-HT in rat caudal artery. Br. J. Pharmacol. 109: 609-611, 1993.
117. CROSS, A. J., CROW, T. J., GERRIER, I. N., JOHNSON, J. A., BLOOM, S. R., AND CORSELLIS, J. A. N.: Serotonin receptor changes in dementia of the Alzheimer type. J. Neurochem. 43: 1574-1581, 1984.
118. CROSS, A. J., SLATER, P., PERRY, E. K., AND PERRY, R. H.: An autoradiographic analysis of serotonin receptors in human temporal cortex changes in Alzheimer-type dementia. Neurochem. Int. 13: 89-96, 1988.
119. (1C) receptors. Trends Pharmacol. Sci. 11: 181-182, 1990.
120. DAVIES, M. F., DEISZ, R. A., PRINCE, D. A., AND PEROUTKA, S. J.: Two distinct effects of 5-hydroxytryptamine on single cortical neurones. Brain Res. 423: 347-352, 1987.
121. 1-like receptors on rat brainstem neurones. Br. J. Pharmacol. 94: 492-499, 1988.
122. DE CHAFFOY, D. E., COURCELLES, D., LEYSEN, J. E., DE CLERCK, F., VAN BELLE, H., AND JANSSEN, P. A. J.: Phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. J. Biol. Chem. 260: 7603-7608, 1985.
123. 1A receptors: possible clinical relevance. In Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications, edited by S. Z. Langer, N. Brunello, G. Racagni, G., and Mendlewicz, Vol. 1, pp. 80-88, J. Int. Acad. Biomed. Drug Res., Karger, Basel, Switzerland, 1992.
124. DE Vivo, M., AND MAAYANI, S.: Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists. Eur. J. Pharmacol. 119: 231-234, 1985.
125. 1A-receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea-pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238: 248-252, 1986.
126. 1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br. J. Pharmacol., 102: 323-330, 1991.
127. 1D receptors involved? Naunyn Schmiedebergs Arch. Pharmacol., 345: 509-515, 1992.
128. 3 receptors are membrane ion channels. Nature (Lond.) 339: 706-709, 1989.
129. DEVEREUX, J., HAEBERLI, P., AND SMITHIES, O.: A comprehensive set of sequence analysing programs for the VAX. Nucleic Acids Res. 12: 387-395, 1984.
130. DOCHERTY, J. R., AND WARNOCK, P.: Prejunctional inhibitory 5-hydroxytryptamine (5-HT) receptors in rat heart and vas deferens. Br. J. Pharmacol. 89: 834P, 1986.
131. 1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935 and urapidil. J. Cardiovasc. Pharmacol. 11: 432-437, 1988.
132. 2 receptor in A7r5 smooth muscle cells. Naunyn Schmiedebergs Arch. Pharmacol. 333: 98-103, 1986.
133. (1A) receptor agonist flesinoxan with that of 8-OH-DPAT in the rat. Eur. J. Pharmacol. 180: 339-349, 1990.
134. (1A) receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat. J. Cardiovasc. Pharmacol. 17: 488-493, 1991.
135. DUMUIS, A., BOUHELAL, R., SEBBEN, M., AND BOCKAERT, J.: A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonised by ICS 205930. Eur. J. Pharmacol. 146: 187-188, 1988.
136. 4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn Schmiedebergs Arch. Pharmacol. 345: 264-269, 1992.
137. 4 positively coupled to adenylate cyclase in neurones. Naunyn Schmiedebergs Arch. Pharmacol. 340: 403-410, 1989.
138. 4 receptor positively coupled to adenylate cyclase in brain. Naunyn Schmiedebergs Arch., Pharmacol. 343: 245-251, 1991.
139. EDVINSSON, L., JANSEN, I., AND OLESEN, J.: Characterisation of human craniovascular 5-hydroxytryptamine receptors. In 5-Hydroxytryptamine Mechanisms in Primary Headaches, edited by J. Olesen and P. R. Saxena, pp. 129-136, Raven Press, New York, 1992.
140. 3 receptor agonists on phosphoinositide hydrolysis in the rat frontocingulate and entorhinal cortices. J. Pharmacol. Exp. Ther. 256: 1025-1032, 1991.
141. EGLEN, R. M., ALVAREZ, R., WONG, E. H. F., JOHNSON, L., PERKINS, L. A., RAMSEY, S., LOURY, D. N., TANG, H.-M., WALLACE, S., AND WHITING, R. L.: Characterisation of the interaction of SDZ 205557 at putative 5-HT, receptors. Br. J. Pharmacol. 105: 275P, 1992a.
142. 4 receptor antagonist. Br. J. Pharmacol. 107: 439P, 1992b.
143. EGLEN, R. M., MONTGOMERY, W. W., AND WHITING, R. L.: Analysis of 5-HT receptors mediating positive chronotropy in isolated guinea-pig atria. Proc. West. Pharmacol. Soc. 31: 516, 1991.
144. 3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro. Br. J. Pharmacol. 101: 513-520, 1990.
145. ELLIOT, P., AND WALLIS, D. I.: Serotonin and L-noradrenaline as mediators of altered excitability in neonatal rat motoneurones studied in vitro. Neuroscience 47: 533-544, 1992.
146. 4 receptors in guinea-pig ascending colon. Eur. J. Pharmacol. 196: 149-155, 1991.
147. 1B binding sites. Naunyn Schmiedebergs Arch. Pharmacol. 332: 1-7, 1986.
148. ERLANDER, M. G., LOVENBERG, T. W., BARON, B. M., DELECEA, L., DANIELSON, P. E., RACKE, M., SLONE, A. L., SIEGEL, B. W., FOYE, P. E., CANNON, K., BRUNS, J. E., AND SUTCLIFFE, J. G.: Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc. Natl.
149. + current in colliculi neurones via activation of a cyclic AMP-dependent protein kinase. Br. J. Pharmacol. 105: 973-979, 1992.
150. FARGIN, A., RAYMOND, J. R., LOHSE, M. J., KOBILKA, B. K., CARON, M. G., AND LEFKOWITZ, R. J.: The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature (Lond.) 335: 358-360, 1988.
151. 1A receptor. J. Biol. Chem. 264: 14848-14852, 1989.
152. FENIUK, W., AND HUMPHREY, P. P. A.: Mechanisms of 5-hydroxytryptamine-induced vasoconstriction. In The Peripheral Actions of 5-Hydroxytryptamine, edited by J. R. Fozard, pp. 100-122, Oxford University Press, Oxford, UK, 1989.
153. FENIUK, W., HUMPHREY, P. P. A., AND PERREN, M. J.: The selective carotid arterial vasoconstrictor action of GR 43175 in anaesthetised dogs. Br. J. Pharmacol. 96: 83-90, 1989.
154. FENIUK, W., HUMPHREY, P. P. A., PERREN, M. J., AND WATTS, A. D.: A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br. J. Pharmacol. 86: 697-704, 1985.
155. FENIUK, W., HUMPHREY, P. P. A., AND WATTS, A. D.: Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein. Br. J. Pharmacol. 67: 247-254, 1979.
156. FENIUK, W., HUMPHREY, P. P. A., AND WATTS A. D.: 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle. Eur. J. Pharmacol. 96: 71-78, 1983.
157. 1 autoreceptors in pig brain cortex synaptosomes and slices. Naunyn Schmiedebergs Arch. Pharmacol. 338: 314-318, 1988.
158. 1A receptors. Eur. J. Pharmacol. 237: 283-291, 1993.
159. 4 receptor subtype. J. Med. Chem. 35: 1486-1489, 1992.
160. FOGUET, M., HOYER, D., PARDO, L. A., PAREKH, A., KLUXEN, F. W., KALKMAN, H. O., STUHMER, W., AND LUBBERT, H.: Cloning and functional characterisation of the rat stomach fundus serotonin receptor. EMBO J. 11: 3481-3487, 1992b.
161. 2 and stomach fundus serotonin receptor genes. Neuroreport 3: 345-348, 1992a.
162. 1C receptor antagonist. J. Med. Chem. 36: 1104-1107, 1993.
163. 4 receptors. Eur. J. Pharmacol. 211: 117-120, 1992.
164. 4 receptor. Med. Res. Rev. 13: 633-662, 1993.
165. FOZARD, J. R.: Neuronal 5-HT receptor in the periphery. Neuropharmacology 23: 1473-1486, 1984a.
166. FOZARD, J. R.: MDL 72222, a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 326: 36-44, 1984b.
167. 3 receptor antagonists. In Serotonin, Actions, Receptors, Pathophysiology (Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology), edited by E. J. Mylecharane, J. A. Angus, I. S. de la Lande, and P. P. A. Humphrey, pp. 204-221, Macmillan Press, Basingstoke, UK, 1989.
168. 3 receptors. In Cardiovascular Pharmacology of 5-Hydroxytryptamine, edited by P. R. Saxena, D. I. Wallis, W. Wouters, and P. Bevan, pp. 101-115, Kluwer, Dordrecht, The Netherlands, 1990.
169. 3 Receptors, edited by M. Hamon, pp. 1-17, Academic Press, London, UK, 1992.
170. 3 Receptor Antagonists, edited by B. Jones, F. D. King, and G. J. Sanger, CRC Inc., Boca Raton, FL, pp. 241-253, 1993.
171. 1C receptor activation: a key step in the initiation of migraine? Trends Pharmacol. Sci. 10: 307-309, 1989.
172. FOZARD, J. R., MOBAROK ALI, A. T. M., AND NEWGROSH, G.: Blockade of serotonin receptors on autonomic neurones by (-)-cocaine and some related compounds. Eur. J. Pharmacol. 59: 195-210, 1979.
173. FRIELING, T., COOKE, H. J., AND WOOD, J. D.: Serotonin receptors on submucous neurons in guinea pig colon. Am. J. Physiol. 261: G1017-G1023, 1991.
174. FURCHGOTT, R. F.: The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In Catecholamines Handbook Exp. Pharmacol. N. S. 33: 283-335, 1972.
175. FURMAN, B. L., AND WATON, N. G.: 5-Hydroxytryptamine and peripheral secretory mechanisms. In The Peripheral Actions of 5-Hydroxytryptamine, edited by J. R. Fozard, pp. 274-300, Oxford University Press, Oxford, UK, 1989.
176. 4 receptor. Br. J. Pharmacol., 111: 332-338, 1994.
177. 3H 5-HT from slices of human frontal cortex membranes. Br. J. Pharmacol. 93: 14P, 1988.
178. GALZIN, A. M., AND LANGER, S. Z.: Modulation of 5-HT release by presynaptic inhibitory and facilitatory 5-HT receptors in brain slices. Adv. Biosci. 82: 59-62, 1991.
179. GAW, A. J., WADSWORTH, R. M., AND HUMPHREY, P. P. A.: Pharmacological characterisation of post-junctional 5-HT receptors in cerebral arteries from the sheep. Eur. J. Pharmacol. 179: 35-44, 1990.
180. GBRSCHENFELD, H. M., AND PAUPARDIN-TRITSCH, D.: Ionic mechanisms and receptor properties underlying the responses of molluscan neurones to 5-hydroxytryptamine. J. Physiol. (Lond.) 243: 427-456, 1974.
181. GERSHON, M. D., WADE, P. R., AND BRANCHEK, T. A.: Peripheral neural 5-HT receptors: subtypes in the enteric nervous system. In Serotonin: From Cell Biology to Pharmacology and Therapeutics, edited by R. Paoletti, P. R. Vanhoutte, N. Brunello, and F. M. Maggi, pp. 361-371, Kluwer Academic Publishers, Dordrecht, The Netherlands, 1990.
182. 1P receptors in the bowel: G-protein coupling, localisation and function. In Serotonin: Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 133-143, Birkhauser Verlag, Basel, Switzerland, 1991.
183. GLENNON, R. A., AND DUKAT, M.: 5-HT receptor ligands - update 1992. Current Drugs: Serotonin, pp. 1-45, 1992.
184. 1A agonist 8-hydroxy-2-di-n-propylaminotetralin-8-OH-DPAT. Eur. J. Pharmacol. 154: 339-342, 1988.
185. 1C receptor-mediated endothelium-dependent relaxation of porcine pulmonary arteries in vitro. In 5-Hydroxytryptamine Mechanisms in Primary Headaches, edited by J. Olesen and P. R. Saxena, pp. 168-172, Raven Press, New York, 1992.
186. 1C-like receptors. Naunyn Schmiedebergs Arch. Pharmacol. 347: 471-477, 1993.
187. GÖTHERT, M., KOLLECKER, P., ROHM, N., AND ZERKOWSKI, H. R.: Inhibitory presynaptic 5-hydroxytryptamine (5-HT) receptor on the sympathetic nerves of human saphenous vein. Naunyn Schmiedebergs Arch. Pharmacol. 332: 317-333, 1986a.
188. GÖTHERT, M., SCHLICKER, E., AND KOLLECKER, P.: Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat. Naunyn Schmiedebergs Arch. Pharmacol. 332: 124-130, 1986b.
189. 3H-PAT. Nature (Lond.) 305: 140-142, 1983.
190. GREEN, J. P., AND MAAYANI, S.: Nomenclature, classification and notation of receptors: 5-hydroxytryptamine receptors and binding sites as examples. In Perspectives on Receptor Classification, edited by J. W. Black, D. H. Jenkinson and P. Gerskowitz, pp. 237-267, Alan R. Liss Inc., New York, 1987.
191. GREENBERG, M. J.: Structure-activity relationship of tryptamine analogues on the heart of Venus mercenaria. Br. J. Pharmacol. 15: 375-388, 1960.
192. 4 receptor: use of a novel antagonist. Br. J. Pharmacol. 108: 106P, 1993a.
193. 4 receptors in guinea-pig and rat brain. Br. J. Pharmacol. 109: 618-624, 1993b.
194. GUDERMAN, T., LEVY, F. O., BIRNBAUMER, M., BIRNBAUMER, L., AND KAUMANN, A. J.: Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine like serotonin receptor. Mol. Pharmacol. 43: 412-418, 1993.
195. 1D subtype. Br. J. Pharmacol. 106: 703-709, 1992.
196. 3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J. Neurochem. 44: 1685-1696, 1985.
197. 1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states. J. Pharmacol. Exp. Ther. 243: 989-995, 1987.
198. 1D type serotonin receptor. Mol. Pharmacol. 40: 143-148, 1991.
199. 1D serotonin receptors in rat: structural and pharmacological comparison of the two cloned receptors. Mol. Cell. Neurosci. 3: 578-587, 1992.
200. 1D binding sites. Br. J. Pharmacol. 102: 227-233, 1991.
201. 1Dβ receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol. 44: 242-246, 1993b.
202. 1Dβ" receptors. Eur. J. Pharmacol. 242: 75-82, 1993a.
203. HAMON, M., COLLIN, E., CHANTREL, D., DAVAL, G., VERGÉ, D., BOURGOIN, S., AND CESSELIN, F.: Serotonin receptors and the modulation of pain. In Serotonin and Pain, ed. J. M. Besson, Elsevier, Amsterdam, pp. 53-72, 1990b.
204. 1B receptor binding sites? Trends Pharmacol. Sci. 7: 336-338, 1986.
205. .3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord. Eur. J. Pharmacol. 164: 315-322, 1989.
206. 1 receptors. Neuropsychopharmacology 3: 349-360, 1990a.
207. 1 receptor distinct from 1A, 1B and 1C subtypes. J. Neurochem. 56: 221-227, 1991.
208. HARTIG, P. R.: Molecular biology of 5-HT receptors. Trends Pharmacol. Sci. 10: 64-69, 1989.
209. 1D receptor genes. Trends Pharmacol. Sci. 13: 152-159, 1992.
210. HEN, R.: Of mice and flies: commonalities among 5-HT receptors. Trends Pharmacol. Sci. 13: 160-165, 1992.
211. HENINGER, G. R., CHARNEY, D. S., AND SMITH, A.: Effects of serotonin receptor agonists and antagonists on neuroendocrine function in rhesus monkeys. Soc. Neurosci. Abstr. 13: 801, 1987.
212. 1D receptor in rat and human brain. J. Neurochem. 50: 1624-1631, 1988.
213. 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 7: 894-903, 1987.
214. 1A receptor ligands with different pharmacological properties. Drugs Future 15: 159-170, 1990.
215. HIEBLE, J. P.: Structure-activity relationships for activation and blockade of β-adrenoceptors. Prog. Basic Clin. Pharmacol. 7: 105-172, 1991.
216. 3" receptor mediating contraction of guinea-pig ileum. Br. J. Pharmacol. 99: 182P, 1990.
217. HILL, J. M., AND KAUFMAN, M. P.: Intrathecal serotonin attenuates the pressor response to static contraction. Brain Res. 550: 157-160, 1991.
218. (1A)-receptor antagonist. J. Med. Chem. 33: 1541-1544, 1990.
219. 1A receptors behavioural and in vivo brain microdialysis studies. Life Sci. 46: 955-963, 1990.
220. 1C receptor mRNA in adult rat brain. FEBS Lett. 247: 453-462, 1989.
221. HOUSTON, D., AND VANHOUTTE, P. M.: Comparison of the serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. J. Pharmacol. Exp. Ther. 244: 1-10, 1988.
222. 1C receptors. Trends Pharmacol. Sci. 9: 89-94, 1988a.
223. 1 recognition sites. J. Recept. Res. 8: 59-81, 1988b.
224. HOYER, D.: 5-Hydroxytryptamine receptors and effector coupling mechanism in peripheral tissues. In The Peripheral Actions of 5-Hydroxytryptamine, edited by J. R. Fozard, pp. 72-99, Oxford University Press, Oxford, UK, 1989.
225. 4 and 5-HT-M receptors. Neuropsychopharmacology 3: 371-383, 1990.
226. HOYER, D., BODDEKE, H., AND SCHOEFFTER, P.: Second messengers in the definition of 5-HT receptors. In Serotonin: Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 117-132, Birkhauser Verlag, Basel, Switzerland, 1991.
227. 125I]iodocyanopindolol. Eur. J. Pharmacol. 118: 1-12, 1985a.
228. 3H]ketanserin. Eur. J. Pharmacol. 118: 13-23, 1985b.
229. 1D binding in rabbit brain. Naunyn Schmiedebergs Arch. Pharmacol. 346: 249-254, 1992.
230. HOYER, D., AND MIDDLEMISS, D. N.: Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci. 10: 131-132, 1989.
231. 3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. Mol. Pharmacol. 33: 303-309, 1988.
232. HOYER, D., PAZOS, A., PROBST, A., AND PALACIOS, J. M.: . Serotonin receptors in the human brain. I. Characterisation and autoradiographic localisation of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res. 376: 85-96, 1986a.
233. HOYER, D., PAZOS, A., PROBST, A., AND PALACIOS, J. M.: Serotonin receptors in the human brain. II. Characterisation and autoradiographic localisation of 5-HT1C and 5-HT2 recognition sites. Brain Res. 376: 97-107, 1986b.
234. 1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigra. Eur. J. Pharmacol. 147: 145-147, 1988.
235. 3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion. Naunyn Schmiedebergs Arch. Pharmacol. 340: 396-402, 1989b.
236. 1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus; a pharmacological characterisation. Naunyn Schmiedebergs Arch. Pharmacol. 339: 252-258, 1989a.
237. HUMPHREY, P. P. A.: Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology 23: 1503-1510, 1984.
238. HUMPHREY, P. P. A.: 5-Hydroxytryptamine receptors and drug discovery. Vol. 1, pp. 129-139, Int. Acad. Biomed. Drug Res., Karger, Basel, Switzerland, 1992.
239. HUMPHREY, P. P. A., AND FENIUK, W.: The pharmacological characterisation of functional neuronal receptors for 5-hydroxytryptamine. In Neuronal Messengers in Vascular Function, Vol. 10, edited by A. Nobin, C. Owman and B. Arneklo-Nobin, pp. 3-19, Elsevier Science Publishers, The Netherlands, 1987.
240. 1-like receptors. In Serotonin, Actions, Receptors, Pathophysiology, edited by E. J. Mylecharane, J. A. Angus, I. S. de la Lande, and P. P. A. Humphrey, pp. 159-168, Macmillan Press, Basingstoke, UK. 1989.
241. HUMPHREY, P. P. A., AND FENIUK, W.: Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol. Sci. 12: 444-446, 1991.
242. HUMPHREY, P. P. A., FENIUK, W., MOTEVALIAN, M., PARSONS, A. A., AND WHALLEY, E. T.: The vasoconstrictor action of sumatriptan on human isolated dura mater. In Serotonin: Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 421-429, Birkhauser Verlag, Basel, Switzerland, 1991.
243. 1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol. 94: 1123-1132, 1988.
244. HUMPHREY, P. P. A., HARTIG, P., AND HOYER, D.: A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14: 233-236, 1993.
245. HUMPHREY, P. P. A., AND RICHARDSON, B. P.: Classification of 5-HT receptors and binding sites: an overview. In Serotonin, Actions, Receptors, Pathophysiology, edited by E. J. Mylecharane, J. A. Angus, I. S. de la Lande, and P. P. A. Humphrey, pp. 204-221, Macmillan Press, Basingstoke, UK, 1989.
246. 4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells. Mol. Brain Res. 10: 251-258, 1991.
247. IMAIZUMI, Y., BABA, M., IMAIZUMI, Y., AND WATANABE, M.: Involvement of endothelium in the relaxation of isolated chick jugular vein by 5-hydroxytryptamine. Eur. J. Pharmacol. 97: 335-336, 1984.
248. IRELAND, S. J., AND TYERS, M. B:. Pharmacological characterisation of 5-hydroxytryptamine-induced depolarisation of the rat isolated vagus nerve. Br. J. Pharmacol. 90: 229-238, 1987.
249. IVERSEN, S. D.: 5-HT and anxiety. Neuropharmacology 23: 1553-1560, 1984.
250. 1B receptor. J. Biol. Chem. 267: 5735-5738, 1992.
251. JULIUS, D.: Molecular biology of serotonin receptors. Annu. Rev. Neurosci. 14: 335-360, 1991.
252. 1C receptor. Science (Washington DC) 214: 558-564, 1988.
253. 1 receptors. Eur. J. Pharmacol. 91: 155-156, 1983.
254. 1D recognition sites. In Serotonin: Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 153-160, Birkhauser Verlag, Basel, Switzerland, 1991a.
255. KALKMAN, H.O., AND FOZARD, J.R.: 5-HT receptor types and their role in disease. Curr. Opin. Neurol. Neurosurg. 4: 560-565, 1991b.
256. 4-like receptors. Naunyn Schmiedebergs Arch. Pharmacol. 342: 619-622, 1990.
257. KAUMANN, A. J.: Regulation of cardiac β-adrenoceptors by antagonists. In Adrenoceptors: Structure, Mechanisms and Function, edited by S. A. Abadi, pp. 221-230, Birkhauser Verlag, Basel, Switzerland, 1991a.
258. 4-like receptors in mammalian atria. J. Neural Transm. 34 (Suppl.): 195-201, 1991b.
259. 4-like receptors in piglet left atrium. Br. J. Pharmacol. 101: 98P, 1991a.
260. KAUMANN, A. J., MURRAY, K. J., BROWN, A. M., SANDERS, L., AND BROWN, M. J.: A receptor for 5-HT in human atrium. Br. J. Pharmacol. 98: 664P, 1989.
261. KAUMANN, A. J., PARSONS, A. A., AND BROWN, A. M.: Human arterial constrictor serotonin receptors. Cardiovasc. Res. 27: 2094-2103, 1993.
262. KAUMANN, A. J., SANDERS, L., BROWN, A. M., MURRAY, K. J., AND BROWN, M. J.: A 5-hydroxytryptamine receptor in human atrium. Br. J. Pharmacol. 100: 879-885, 1990.
263. 4 -like receptor in human right atrium. Naunyn Schmiedebergs Arch. Pharmacol. 344: 150-159, 1991b.
264. KENAKIN, T. P.: Challenges for receptor theory as a tool for drug and drug receptor classification. Trends Pharmacol. Sci. 10: 18-22, 1989.
265. KENAKIN, T. P.: Synoptic receptor function. Trends Pharmacol. Sci. 14: 431-432, 1993.
266. KENAKIN, T. P., BOND, R. A., AND BONNER, T. I.: Definition of pharmacological receptors. Pharmacol. Rev. 44: 351-362, 1992.
267. 1B receptors. Psychopharmacology 96: 93-100, 1988a.
268. 1C receptors. Br. J. Pharmacol. 94: 137-147, 1988b.
269. 1C receptor antagonists. Eur. J. Pharmacol. 164: 445-454, 1989.
270. 3 antagonist (R)-zacopride labels an additional high affinity site in the central nervous system. Eur. J. Pharmacol. 211: 133-136, 1992.
271. 4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch. Pharmacol. 345: 270-275, 1992.
272. 3 receptor binding sites in rabbit ileum: comparison with those in rat ileum and rat brain. Neurochem. Int. 19: 389-396, 1991.
273. 3 receptor agonist. Eur. J. Pharmacol. 182: 193-197, 1990b.
274. 3 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 342: 22-30, 1990a.
275. 3 receptors in rat brain using radioligand binding. Nature (Lond.) 330: 746-748, 1987.
276. 3 receptor. Biochem. Soc. Trans. 20: 118-121, 1991.
277. 1P receptors in the guinea-pig pancreas. Am J. Physiol. 262: G553-G566, 1992.
278. KOBILKA, B. K., FRIELLE, T., COLLINS, S., YANG-FENG, T., KOBILKA, T. S., FRANCKE, U., LEFKOWITZ, R. J., AND CARON, M. G.: An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature (Lond.) 329: 75-77, 1987.
279. 1B receptor ligand. Drug Dev. Res. 25: 67-74, 1992a.
280. 1B receptor: binding studies in rat brain membranes. J. Neurochem. 68: 1268-1276, 1992b.
281. 1C receptors. Neurosci. Behav. Rev. 16: 95-105, 1992.
282. KOENIG, J. I., GUDELSKY, G. A., AND MELTZER, H. Y.: Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur. J. Pharmacol. 137: 1-8, 1987.
283. 2F) from rat stomach fundus. Mol. Pharmacol. 42: 549-557, 1992.
284. 3 receptors. In Central and Peripheral 5-HT3 Receptors, edited by M. Hamon, pp. 157-187, Academic Press, London, UK, 1992.
285. LARKMAN, P. M., AND KELLY, J. S.: Pharmacological characterisation of the receptor mediating 5-HT evoked motoneuronal depolarisation in vitro. In Serotonin: Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 310-321, Birkhauser Verlag, Basel, Switzerland, 1991.
286. 4 receptor subtype. Neuroscience 47: 999-1007, 1992.
287. 2-like receptors. Can they be classified with the available antagonists? Br. J. Pharmacol. 88: 585-593, 1986.
288. LEFF, P., AND MARTIN, G. R.: The classification of 5-HT receptors using tryptamine analogues. In Serotonin, Actions, Receptors, Pathophysiology (Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology), edited by E. J. Mylecharane, J. A. Angus, I. S. de la Lande, and P. P. A. Humphrey, pp. 195-203, Macmillan Press, Basingstoke, UK, 1989.
289. 2-like receptors using tryptamine agonist and antagonist analogues. Br. J. Pharmacol. 89: 493-499, 1986.
290. LEFF, P., MARTIN, G. R., AND MORSE, J. M.: Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues. Br. J. Pharmacol. 91: 321-331, 1987.
291. LEFKOWITZ, R. J., KOBILKA, B. K., AND CARON, M. G.: The new biology of drug receptors. Biochem. Pharmacol. 38: 2941-2948, 1989.
292. 2 receptors. Endocrinology 120: 1498-1502, 1987.
293. 1E) in human brain: interaction with a GTP-binding protein. J. Neurochem. 53: 465-471, 1989.
294. LEVY, F. O., GUDERMANN, T., BIRBAUMER, M., KAUMANN, A. J., AND BIRNBAUMER, L.: Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclase. FEBS Lett. 296: 201-206, 1992a.
295. 1D subtype. J. Biol. Chem. 267: 7553-7562, 1992b.
296. LEYSEN, J. E., AWOUTERS, F., KENNIS, L., LADURON, P. M., VANDENBERK, J., AND JANSSEN, P. A. J.: Receptor binding profile of 5-HT antagonists. Life Sci. 28: 1015-1022, 1981.
297. 3H]ligand for serotonin 2 receptor binding sites. Mol. Pharmacol. 21: 301-314, 1982.
298. 2)-receptor binding sites: effects of neuronal lesions. In CNS Receptors - from molecular pharmacology to behaviour, edited by P. Mandel and F. V. de Feudis, pp. 373-383, Raven Press, New York, 1983.
299. LIBERT, F., PARMENTIER, M., LEFORT, A., DINSART, C., VAN SANDE, J., MAENHAUT, C., SIMONS, M. J., DUMONT, J. E., AND VASSART, G.: Selective amplification and cloning of four new members of the G-protein-coupled receptor family. Science (Washington DC) 244: 569-572, 1989.
300. 1D in the rabbit and guinea-pig brain cortex. Naunyn Schmiedebergs Arch. Pharmacol. 343: 353-364, 1991.
301. 2-like receptor. Expression in brain, heart and intestine. FEBS Lett. 312: 203-207, 1992.
302. 7) implicated in the regulation of mammalian circadian rhythms. Neuron 11: 449-458, 1993b.
303. 1E-like rat and human 5-hydroxytryptamine receptor genes. Proc. Natl. Acad. Sci. USA 90: 2184-2188, 1993a.
304. 1E) binding sites in human brain. Eur. J. Pharmacol. 222: 137-142, 1992.
305. 1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes. Proc. Natl. Acad. Sci. USA 84: 4322-4336, 1987a.
306. 1C receptors are encoded by a 5-6 kbase mRNA size class and are functionally expressed in injected Xenopus oocytes. J. Neurosci. 7: 1159-1165, 1987b.
307. 1 receptors and behaviour. Neurosci. Biobehav. Rev. 16: 83-93, 1992.
308. 2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery. Br. J. Pharmacol. 97: 921-933, 1989.
309. 1B agonist and rotationally restricted phenolic analogue of 5 methoxy-3-1 2 5 6-tetrahydropyrid-4-ylindole. J. Med. Chem. 33: 2087-2093, 1990.
310. 1D serotonin receptor. Biochem. Biophys. Res. Commun. 180: 1460-1468, 1991.
311. 1D-like sites in guinea-pig brain. Eur. J. Pharmacol. 205: 323-324, 1991.
312. 3 receptors of rabbit, mouse and guinea-pig nodose ganglion neurones. Br. J. Pharmacol. 104: 68P, 1991.
313. 1 sites in the rat brain. Brain Res. 291: 159-163, 1984.
314. 3 receptor, a serotoningated ion channel. Science (Washington DC) 254: 432-437, 1991.
315. 1B serotonin receptor: cloning, functional expression and localisation in motor control centers. Proc. Natl. Acad. Sci. USA 89: 3020-3024, 1992.
316. MARTIN, G. R., BROWNING, C., AND GILES, H.: Further characterisation of an atypical 5-HT receptor mediating endothelium-dependent vasorelaxation. Br. J. Pharmacol. 110: 137P, 1993.
317. MARTIN, G. R., LEFF, P., CAMBRIDGE, D., AND BARRETT, V. J.: Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn Schmiedebergs Arch. Pharmacol. 336: 365-373, 1987.
318. MARTIN, G. R., AND MACLENNAN, S. J.: Analysis of the receptor in rabbit saphenous vein exemplifies the problems of using exclusion criteria for receptor classification. Naunyn Schmiedebergs Arch. Pharmacol. 342: 111-119, 1990.
319. MARTIN, G. R., PRENTICE, D. J., AND MACLENNAN, S. J.: The 5-HT receptor in rabbit saphenous vein. Identity with the 5-HT1D recognition site? Fundam. Clin. Exp. Pharmacol. 5: 417, 1991.
320. 1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater. Br. J. Pharmacol. 104: 3-4, 1991.
321. 5B receptors define a new family of serotonin receptors: cloning, functional expression and chromosomal localisation. Mol. Pharmacol. 43: 313-319, 1993.
322. 1B receptors mediating inhibition of acetylcholine release. Eur. J. Pharmacol. 129: 333-337, 1986.
323. 2 receptors. Eur. J. Pharmacol. 145: 31-38, 1988.
324. 1D receptors in human cerebral cortex. J. Neurochem. 60: 1179-1182, 1993.
325. MAWE, G. M., BRANCHEK, T. A., AND GERSHON, M. D.: Peripheral neural serotonin receptors: identification and characterisation with specific antagonists and agonists. Proc. Natl. Acad. Sci. USA 83: 9799-9803, 1986.
326. MAWE, G. M., BRANCHEK, T. A., AND GERSHON, M. D.: Blockade of 5-HT-mediated enteric slow EPSPs by BRL 24924: gastrokinetic effects. Am. J. Physiol. 257: G386-G396, 1989.
327. 1-like subtype. Proc. Natl. Acad. Sci. USA 89: 5517-5521, 1992.
328. 3 receptor solubilised from NCB 20 cells. Biochem. J. 269: 623-62, 1990.
329. MCQUEEN, D. S., AND MIR, A. K.: 5-Hydroxytryptamine and cardiopulmonary and carotid body reflex mechanisms. In The Peripheral Actions of 5-Hydroxytryptamine, edited by J. R. Fozard, pp. 301-326, Oxford University Press, Oxford, UK, 1989.
330. 4 receptor mediating tachycardia in isolated piglet right atrium. Br. J. Pharmacol. 110: 1023-1030, 1993.
331. 3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine. Eur. J. Pharmacol. 67: 371-382, 1980.
332. 1C receptor mRNA in the rodent brain examined by in situ hybridisation histochemistry. Comparison with receptor binding distribution. Neuroscience 35: 577-591, 1990a.
333. 2 receptor by in situ hybridisation histochemistry. Correlation with the distribution of receptor sites. Brain Res. 524: 139-143, 1990b.
334. MEYERHOF, W., OBERMÜLLER, F., FEHR, S., AND RICHTER, D.: A novel rat serotonin receptor: primary structure, pharmacology and expression pattern in distinct brain regions. DNA Cell Biol. 12: 401-409, 1993.
335. 3H]S-HT recognition site. Naunyn Schmiedebergs Arch. Pharmacol. 327: 18-22, 1984.
336. 1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. J. Pharm. Pharmacol. 37: 434-438, 1985.
337. MIDDLEMISS, D. N.: Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonists. Eur. J. Pharmacol. 120: 51-54, 1986.
338. MIDDLEMISS, D. N., BREMER, M. E., AND SMITH, S. M.: A pharmacological analysis of the 5-HT receptors mediating inhibition of 5-HT release in the guinea-pig frontal cortex. Eur. J. Pharmacol. 157: 101-107, 1988.
339. 1A receptor expression in HeLa cells. J. Clin. Invest. 86: 1799-1805, 1990.
340. 1E) serotonin receptors in human brain. Neurosci. Lett. 136: 223-226, 1992.
341. MOLDERINGS, G. J., ENGEL, G., ROTH, E., AND GÖTHERT, M.: Characterisation of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery. Naunyn Schmiedebergs Arch. Pharmacol. 340: 300-308, 1989a.
342. 1B receptors. Naunyn Schmiedebergs Arch. Pharmacol. 336: 245-250, 1987.
343. MOLDERINGS, G. J., GÖTHERT, M., FINK, K., ROTH, E., AND SCHLICKER, E.: Inhibition of noradrenaline release in the pig coronary artery via a novel serotonin receptor. Eur. J. Pharmacol. 164: 213-222, 1989b.
344. (1D) subtype. Naunyn Schmiedebergs Arch. Pharmacol. 342: 371-377, 1990.
345. MONFERINI, E., GAETANI, P., RODRIGUEZ, Y., BAENA, R., GIRALDO, E., PARENTI, M., ZOCCHETTI, A., AND RIZZI, C. A.: Pharmacological characterisation of the 5-hydroxytryptamine receptor coupled to adenylyl cyclase stimulation in human brain. Life Sci. 52: 61-65, 1993.
346. MONSMA, F. J., JR., SHEN, Y., WARD, R. P., HAMBLIN, M. W., AND SIBLEY, D. R.: Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43: 320-327, 1993.
347. 1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum. J. Pharmacol. Exp. Ther. 249: 535-543, 1989.
348. 2 receptors. In Cardiovascular Pharmacology of 5-Hydroxytryptamine, edited by P. R. Saxena, D. I. Wallis, W. Wouters, and P. Bevan, pp. 81-100, Kluwer Academic Publishers, Dordrecht, The Netherlands, 1990.
349. 3 receptor of the rat, mouse and guinea pig superior cervical ganglion may be different. Br. J. Pharmacol. 102: 615-620, 1991.
350. 2 receptors to decrease potassium conductance in rat nucleus accumbens neurones. J. Physiol. (Lond.) 417: 1-12, 1989.
351. ORWIN, J. M., AND FOZARD, J. R.: Blockade of the flare response to intradermal 5-hydroxytryptamine in man by MDL 72222, a selective antagonist at neuronal 5-hydroxytryptamine receptors. Eur. J. Clin. Pharmacol. 30: 209-212, 1986.
352. 1D receptors in the human brain using a new iodinated ligand. Mol. Brain Res. 346: 175-179, 1992.
353. PALACIOS, J. M., WAEBER, C., MENGOD, G., AND POMPEIANO, M.: Molecular neuroanatomy of 5-HT receptors. In Serotonin: Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 5-20, Birkhauser Verlag, Basel, Switzerland, 1991.
354. 1-like receptors in rabbit isolated basilar arteries. Eur. J. Pharmacol. 174: 189-196, 1989.
355. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br. J. Pharmacol. 96: 434-440, 1989.
356. 3 receptors in rat cerebral cortex and nucleus accumbens. Br. J. Pharmacol. 103: 1790-1794, 1991.
357. PAZOS, A., CORTES, R., AND PALACIOS, J. M.: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346: 231-249, 1985.
358. PAZOS, A., HOYER, D., AND PALACIOS, J. M.: The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site. Eur. J. Pharmacol. 106: 539-546, 1984.
359. PAZOS, A., AND PALACIOS, J. M.: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346: 205-230, 1985.
360. PAZOS, A., PROBST, A., AND PALACIOS, J. M.: Serotonin receptors in the human brain. III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21: 97-122, 1987a.
361. PAZOS, A., PROBST, A., AND PALACIOS, J. M.: Serotonin receptors in the human brain. IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21: 123-139, 1987b.
362. PEROUTKA, S. J.: 5-Hydroxytryptamine receptor subtypes. Annu. Rev. Neurosci. 11: 45-60 1988.
363. PEROUTKA, S. J.: 5-Hydroxytryptamine receptors. J. Neurochem. 60: 408-416, 1993.
364. PEROUTKA, S. J., HAMIK, A., HARRINGTON, M. A., HOFFMAN, A. J., MATHIS, C. A., PIERCE, P. A., AND WANG, S. S. H.: (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes. Mol. Pharmacol. 34: 537-542, 1988.
365. 1A receptors. J. Pharmacol. Exp. Ther. 237: 901-906, 1986.
366. 1D binding sites. Eur. J. Pharmacol. 163: 133-136, 1989.
367. 1D/1B agent. Life Sci. 49: 409-418, 1991.
368. 3H] spiroperidol. Mol. Pharmacol. 16: 687-699, 1979.
369. 1D binding sites in human brain membranes. Synapse 3: 61-66, 1989.
370. PERREN, M. J., FENIUK, W., AND HUMPHREY, P. P. A.: The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR 43175. Cephalalgia 9 (Suppl.): 41-46, 1989.
371. 1D subtype. Br. J. Pharmacol. 102: 191-197, 1991.
372. 3 receptors in neuronal cell lines. Trends Pharmacol. Sci. 10: 172-175, 1989.
373. 3 receptor-mediated electrical responses in nodose ganglion neurones and clonal neuroblastoma cells maintained in culture. In Serotonin: Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 84-94, Birkhauser Verlag, Basel, Switzerland, 1991.
374. PLASSAT, J. L., AMLAIKY, N., AND HEN, R.: Molecular cloning of a mammalian serotonin receptor that activates adenylyl cyclase. Mol. Pharmacol. 44: 229-236, 1993.
375. 1D receptor family. EMBO J. 11: 4779-4786, 1992.
376. 3 receptors in mammalian hindbrain. Trends Pharmacol. Sci. 11: 135-137, 1990.
377. 2 receptor. EMBO J. 7: 4135-4140, 1988.
378. 4 receptors. Mol. Pharmacol. 41: 346-351, 1992.
379. RADJA, F., LAPORTE, A. M., DAVAL, G., VERGÉ, D., GOZLAN, H., AND HAMON, M.: Autoradiography of serotonin receptor subtypes in the central nervous system. Neurochem. Int. 18: 1-15, 1991.
380. 1 receptors modulating transmitter release in rat cerebellum. J. Pharmacol. Exp. Ther. 237: 644-648, 1986.
381. (1A) and histamine H1 receptors in HeLa cells stimulate phosphoinositide hydrolysis and phosphate uptake via distinct G-protein pools. J. Biol. Chem. 266: 372-379, 1991.
382. (1A) receptor expressed in HeLa cells stimulates sodium-dependent phosphate uptake via protein kinase C. J. Biol. Chem. 264: 21943-21950, 1989.
383. REEVES, J. J., BUNCE, K. T., AND HUMPHREY, P. P. A.: Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in rat oesophagus. Br. J. Pharmacol. 103: 1067-1072, 1991.
384. REEVES, J. J., BUNCE, K. T., HUMPHREY, P. P. A., AND GUNNING, S. J.: Further characterisation of the 5-HT receptor mediating smooth muscle relaxation in rat oesophagus. Br. J. Pharmacol. 98: 800P, 1989.
385. 2 receptors in a glial cell line. In Serotonin: Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 69-83, Birkhauser Verlag, Basel, Switzerland, 1991.
386. 4 receptor. Naunyn Schmiedebergs Arch. Pharmacol. 346: 496-503, 1992.
387. RICHARDS, M. H.: Pharmacology and second messenger interactions of cloned muscarinic receptors. Biochem. Pharmacol. 42: 1645-1653, 1991.
388. RICHARDSON, B. P., ENGEL, G., DONATSCH, P., AND STADLER, P. A.: Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature (Lond.) 316: 126-131, 1985.
389. RICHARDSON, B. P., AND HOYER, D.: Selective agonists and antagonists at 5-hydroxytryptamine receptor subtypes. In Serotonin: From Cell Biology to Pharmacology and Therapeutics, edited by R. Paoletti et al., pp. 265-276, Kluwer Academic Publishers, Dordrecht, The Netherlands, 1990.
390. ROBERTS, M. H. T., AND DAVIES, M.: In vivo electrophysiology of receptors mediating the central nervous system actions of 5-hydroxytryptamine. In Serotonin: Actions, Receptors and Pathophysiology, edited by E. J. Mylecharane, J. A. Angus, I. S. de la Lande, and P. P. A. Humphrey, pp. 70-76, Macmillan, London, UK, 1989.
391. ROBERTS, M. H. T., DAVIES, M., GIRDLESTONE, D., AND FOSTER, G. A.: Effects of 5-hydroxytryptamine agonists and antagonists on the responses of rat spinal motoneurones to raphé obscurus stimulation. Br. J. Pharmacol. 95: 437-448, 1988.
392. ROTH, B. L., NAKAKI, T., CHUANG, D.-M., AND COSTA, E.: Aortic recognition sites for serotonin (5-HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology 23: 1223-1225, 1984.
393. 6) receptor - molecular cloning, localisation and stimulation of cAMP accumulation. Biochem. Biophys. Res. Commun. 193: 268-276, 1993a.
394. 7) activating cAMP formation. Proc. Natl. Acad. Sci. USA 90: 8547-8551, 1993b.
395. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery. Br. J. Pharmacol. 102: 386-390, 1991a.
396. 1C receptors in pig choroid plexus. Naunyn Schmiedebergs Arch. Pharmacol. 344: 137-142, 1991b.
397. SAITO, K., MARKOWITZ, S., AND MOSKOWITZ, M. A.: Ergot alkaloids block neurogenic extravasation in dura mater. Proposed action in vascular headache. Ann. Neurol. 24: 732-737, 1988.
398. 1C receptor subtypes. Biochem. Biophys. Res. Commun. 181: 1469-1478, 1991.
399. 3 receptor antagonism by BRL 43694 (granisetron). Eur. J. Pharmacol. 159: 113-124, 1989.
400. 3 receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord. Neuroreport 1: 104-106, 1990.
401. SAXENA, P. R., BOM, A. H., AND VERDOUW, P. D.: Characterisation of 5-hydroxytryptamine receptors in the cranial vasculature. Cephalalgia 9 (Suppl. 9): 15-22, 1989.
402. 1-like" receptors. Naunyn Schmiedebergs Arch. Pharmacol. 333: 198-204, 1986.
403. 2 type. J. Auton. Pharmacol. 5: 101-107, 1985a.
404. SAXENA, P. R., KOEDAM, N. A., HEILIGERS, J., AND HOF, R. P.: Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia 3: 71-81, 1983.
405. 1 receptors. Arch. Int. Pharmacodyn. 277: 235-252, 1985.
406. 1-like receptors. Naunyn Schmiedebergs Arch. Pharmacol. 330: 121-129, 1985b.
407. SAXENA, P. R., AND VILLALÓN, C. M.: Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol. 15 (Suppl. 7): S17-S34, 1990.
408. SAXENA, P. R., AND VILLALÓN, C. M.: 5-Hydroxytryptamine: a chameleon in the heart. Trends Pharmacol. Sci. 12: 223-227, 1991.
409. 4 receptor. Life Sci. 51: 583-592, 1992.
410. 1D binding site. Soc. Neurosci. Abstr. 221.8, 1988.
411. SCHIPPER, J., VAN DER HEYDEN, J. A. M., AND OLIVIER, B.: Species differences in serotonin autoreceptors. Soc. Neurosci. Abstr. 13: 345, 1987.
412. 1D receptor subtype. Naunyn Schmiedebergs Arch. Pharmacol. 340: 45-51, 1989.
413. 1A receptor antagonist. Eur. J. Pharmacol. 244: 251-257, 1993.
414. 1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol. 95: 975-985, 1988.
415. 1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some β-adrenoceptor antagonists. Naunyn Schmiedebergs Arch. Pharmacol. 340: 285-292, 1989a.
416. 1B ligands exist? Naunyn Schmiedebergs Arch. Pharmacol. 339: 675-683, 1989b.
417. 1D receptors. Naunyn Schmiedebergs Arch. Pharmacol. 340: 135-138, 1989c.
418. 1D receptor subtype. J. Pharmacol. Exp. Ther. 252: 387-395, 1990.
419. 1-like receptor mediating contraction of guinea-pig iliac artery. Eur. J. Pharmacol. 219: 295-301, 1992.
420. 1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 337: 602-608, 1988.
421. SCHOEMAKEH, R. G., DU, X. Y., BAX, W. A., AND SAXENA, P. R.: 5-Hydioxytryptamine increases contractile force in porcine right atrium but not left ventricle. Naunyn Schmiedebergs Arch. Pharmacol. 346: 486-489, 1992.
422. SCHOEMAKER, R. G., DU, X. Y., BAX, W. A., AND SAXENA, P. R.: 5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur. J. Pharmacol. 239: 103-105, 1993.
423. SECREST, R. J., LUCAITES, V. L., MENDELSOHN, L. G., AND COHEN, M. L.: Protein kinase C translocation in rat stomach fundus: effects of serotonin, carbamylcholine and phorbol dibutyrate. J. Pharmacol. Exp. Ther. 256: 103-109, 1991.
424. 1D binding sites in the central nervous system. CR Acad. Sci. (Paris) 312: 655-661, 1991.
425. 3 receptors in NIE-115 neuroblastoma cells. Br. J. Pharmacol. 104: 536-540, 1991.
426. 1B receptors coupled to a Giprotein. Nature (Lond.) 335: 254-256, 1988.
427. (1A) antagonist, BMY 7378. Eur. J. Pharmacol. 176: 331-340, 1990.
428. 7 serotonin receptor subtype. J. Biol. Chem. 268: 18200-18204, 1993.
429. SHENKER, A., MAAYANI, S., WEINSTEIN, H., AND GREEN, J. P.: Enhanced serotonin-stimulated adenylate cyclase activity in membranes from adult guinea-pig hippocampus. Life Sci. 32: 2335-2342, 1983.
430. SHENKER, A., MAAYANI, S., WEINSTEIN, H., AND GREEN, J. P.: Two 5-HT receptors linked to adenylate cyclase in guinea-pig hippocampus are discriminated by 5-carboxamidotryptamine and spiperone. Eur. J. Pharmacol. 109: 427-429, 1985.
431. SHENKER, A., MAAYANI, S., WEINSTEIN, H., AND GREEN, J. P.: Pharmacological characterisation of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea-pig hippocampal membranes. Mol. Pharmacol. 31: 357-367, 1987.
432. 1D receptor antagonist. Br. J. Pharmacol. 110: 9P, 1993.
433. STARKEY, S. J., AND SKINGLE, M.: Effects of WAY 100135, 8-OH-DPAT and sumatriptan on 5-HT release evoked by a single electrical pulse in slices of guinea-pig dorsal raphe nucleus. Br. J. Pharmacol. 108: 100P, 1993.
434. STRANGE, P. G.: The structure and mechanisms of neurotransmitter receptors. Implications for the structure and function of the central nervous system. Biochem J. 249: 309-318, 1988.
435. STRAUSS, M. B.: Familiar Medical Quotations. Little Brown and Company, Boston, MA, 1968.
436. SUGDEN, D.: 5-Hydroxytryptamine amplifies β-adrenergic stimulation of N-acetvltransferase activity in rat pinealocytes. J. Neurochem. 55: 1655-1658, 1990.
437. SUMNER, M. J.: Characterisation of the 5-HT receptor mediating endothelium-dependent relaxation in porcine vena cava. Br. J. Pharmacol. 102: 938-942, 1991.
438. SUMNER, M. J., FENIUK, W., AND HUMPHREY, P. P. A.: Further characterisation of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava. Br. J. Pharmacol. 97: 292-300, 1989.
439. 1 receptor-induced smooth muscle contraction in dog saphenous vein. Br. J. Pharmacol. 105: 603-608, 1992.
440. SUMNER, M. J., AND HUMPHREY, P. P. A.: Characterisation of the endothelial-dependent relaxation of neonatal porcine vena cava evoked by 5-hydroxytryptamine. Br. J. Pharmacol. 95: 788P, 1988.
441. 1D binding sites in porcine brain can be subdivided by GR 43175. Br. J. Pharmacol. 98: 29-31, 1989.
442. SUMNER, M. J., AND HUMPHREY, P. P. A.: Sumatriptan (GR 43175) inhibits cyclic AMP accumulation in dog isolated saphenous vein. Br. J. Pharmacol. 99: 219-220, 1990.
443. SURPRENANT, A., AND CRIST, J.: Electrophysiological characterisation of functionally distinct 5-hydroxytryptamine receptors on guinea-pig sub-mucous plexus. Neuroscience 24: 283-295, 1988.
444. 1-like receptor. Br. J. Pharmacol. 107: 322-328, 1992.
445. TADIPATRI, S., VAN HEUVEN-NOLSEN, D., FENIUK, W., AND SAXENA, P. R.: Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery. Br. J. Pharmacol. 104: 887-894, 1991.
446. TAKAKI, M., BRANCHER, T. A., TAMIR, H., AND GERSHON, M. D.: Specific antagonism of enteric neural serotonin receptors by dipeptides of 5-hydroxytryptophan: evidence that serotonin is a mediator of slow excitation in the myenteric plexus. J. Neurosci. 5: 1769-1780, 1985.
447. TAM, F. S.-F., HILLER, K., AND BUNCE, K.: Investigation of the 5-HT receptor type involved in inhibition of spontaneous activity of human colonic circular muscle. Br. J. Pharmacol. 106: 25P, 1992.
448. TANG, W.-J., AND GILMAN, A. G.: Type-specific regulation of adenylyl cyclase by G-protein βγ subunits. Science (Washington DC), 254: 1500-1503, 1991.
449. 1A binding site. J. Pharmacol. Exp. Ther. 236: 118-125, 1986.
450. 2 receptor subtypes. Mol. Pharmacol. 38: 594-598, 1990.
451. TOHDA, M., AND NOMURA, Y.: Serotonin stimulates both cytosolic and membrane-bound guanylate cyclase in NG108-15 cells. J. Neurochem. 55: 1800-1805, 1990.
452. TOHDA, M., SAKUMA, I., AND NOMURA, Y.: The slow cyclic GMP increase caused by serotonin in NG108-15 cells is not inhibited by antagonists of known serotonin receptors: possible existence of a new receptor subtype coupled with membrane-bound guanylate cyclase. J. Neurochem. 57: 714-717, 1991.
453. TONINI, M., GALLIGAN, J. J., AND NORTH, R. A.: Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea-pig ileum. Gastroenterology 96: 1257-1264, 1989.
454. 4 receptors and gastrointestinal prokinetic action. Pharmacol. Res. 24: 5-14, 1991.
455. 4 receptor agonists facilitate cholinergic transmission in the circular muscle of guinea-pig ileum: antagonism by tropisetron and DAU 6285. Life Sci. 50: 173-178, 1992.
456. 1A receptor-related anxiolytics. Trends Pharmacol. Sci. 8: 432-437, 1987.
457. TREVETHICK, M. A., FENIUK, W., AND HUMPHREY, P. P. A.: 5-Hydroxytryptamine-induced relaxation of neonatal porcine vena cava in vitro. Life Sci. 35: 477-486, 1984.
458. TREVETHICK, M. A., FENIUK, W., AND HUMPHREY, P. P. A.: 5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava. Life Sci. 38: 1521-1528, 1986.
459. TRICKLEBANK, M. D.: The behavioural response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. Trends Pharmacol. Sci. 6: 403-407, 1985.
460. TRICKLEBANK, M. D.: Behavioural actions of 5-HT. In Pharmacology: Proceedings of the 10th International Congress of Pharmacology, edited by M. J. Rand and C. Raper, pp. 299-302, Excerpta Medica, Amsterdam, 1987.
461. 4 receptor involvement in the relaxations induced by 5-HT in the rat ileum. Br. J. Pharmacol. 104: 151P, 1991.
462. TULADHAR, B. R., COSTALL, B., AND NAYLOR, R. J.: Variation in the relaxation response to 5-HT in different regions of the rat small intestine. Br. J. Pharmacol. 105: 278P, 1992.
463. 4 receptors and potential therapeutic implications. Drugs Future 16: 1011-1026, 1991.
464. 3 Receptors. Ann. N. Y. Acad. Sci. 600: 194-205, 1990.
465. UEZONO, Y., BRADLEY, J., MIN, C., MCCARTY, N. A., QUICK, M., RIORDAN, J. R., CHAVKIN, C., ZINN, K., LESTER, H. A., AND DAVIDSON, N.: Receptors that couple to two classes of G-proteins increase cAMP and activate CFTR expressed in Xenopus oocytes. Receptors Channels 1: 233-241, 1993.
466. (1D)-binding sites. Eur. J. Pharmacol. 183: 1106-1107, 1990.
467. 1-like receptors mediate contractions of the rabbit saphenous vein. Eur. J. Pharmacol. 191: 375-382, 1990.
468. VANE, J. R.: The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation. Br. J. Pharmacol. Chemother. 14: 87-98, 1959.
469. VENTER, J. C., DI PORZIO, U., ROBINSON, D. A., SHREEVE, S. M., LAI, J., KERLAVAGE, A. R., FRACEK, S. P., LENTES, K. U., AND FRASER, C. M.: Evolution of neurotransmitter receptor systems. Prog. Neurobiol. 30: 105-169, 1988.
470. 1 receptor subtypes in the brain of control or 5,7-dihydroxytryptaminetreated rats. J. Neurosci. 6: 3473-3482, 1986.
471. 4 receptor. Br. J. Pharmacol. 100: 665-667, 1990.
472. 4 receptor mediating tachycardia in the pig. Br. J. Pharmacol. 102: 107-112, 1991.
473. 1B receptor. EMBO J. 10: 4017-4023, 1991.
474. WADE, P. R., MAWE, G. M., BRANCHEK, T. A., AND GERSHON, M. D.: Use of stereoisomers of zacopride to analyse actions of 5-hydroxytryptamine on enteric neurones. Am. J. Physiol., 260: G80-G90, 1991.
475. 1 receptors in the vertebrate brain: regional distribution examined by autoradiography. Naunyn Schmiedebergs Arch. Pharmacol. 340: 486-494, 1989a.
476. 1D) in the human brain by autoradiography. Neurosci. Lett. 88: 11-16, 1988a.
477. 3 receptors in mouse CNS. Eur. J. Pharmacol. 151: 351-352, 1988b.
478. 3 receptors in the human brain: autoradiographic visualisation. Neuroscience 31: 393-400, 1989b.
479. (1D) agent in monkey and human brains as shown by autoradiography. Synapse 4: 168-170, 1989c.
480. 1D receptor: a progress review. Neurochem. Res. 15: 567-582, 1990.
481. 1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn Schmiedebergs Arch. Pharmacol. 337: 595-601, 1988c.
482. 1D receptors in the guinea-pig and pigeon brain: radioligand binding and biochemical studies. Naunyn Schmiedebergs Arch. Pharmacol. 340: 479-485, 1989d.
483. 4 receptor in urinary bladder of rhesus and cynomolgus monkeys. Br. J. Pharmacol., 111: 213-218, 1994.
484. 4 receptor in rat oesophagus and monkey bladder. Br. J. Pharmacol. 107: 125P, 1992.
485. 4 receptor in tunica muscularis mucoeae of rat oesophagus and ileum of guinea-pig: role of endogenous 5-hydroxvtryptamine. J. Pharmacol. Exp. Ther. 264: 654-661, 1993.
486. 2F receptor. Mol. Pharmacol. 43: 419-426, 1993.
487. WANG, H.-Y., EBERLE-WANG, K., SIMANSKY, K. J., AND FRIEDMAN, E.: Serotonin-induced muscle contraction in rat stomach fundus is mediated by a Gαzlike guanine nucleotide binding protein. J. Pharmacol. Exp. Ther. 267: 1002-1011, 1993.
488. WALLIS, D. I.: Interaction of 5-hydroxytryptamine with autonomic and sensory neurones. In The Peripheral Actions of 5-Hydroxytryptamine, edited by J. R. Fozard, pp. 220-246, Oxford University Press, Oxford, UK, 1989.
489. WALLIS, D. I., CONNELL, L. A., AND KVALTINOVA, Z.: Further studies on the action of 5-hydroxytryptamine on lumbar motoneurones in the rat isolated spinal cord. Naunyn Schmiedebergs Arch. Pharmacol. 343: 344-352, 1991.
490. WALLIS, D. I., AND ELLIOTT, P.: The electrophysiology of 5-HT. In Serotonin: Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena, pp. 203-219, Birkhauser Verlag, Basel, Switzerland, 1991.
491. 4 receptor antagonist. Br. J. Pharmacol. 110: 15P, 1993.
492. 4 receptor. Br. J. Pharmacol. 105: 279P, 1992.
493. WATTS, A. D., FENIUK, W., AND HUMPHREY, P. P. A.: A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein. J. Pharm. Pharmacol. 33: 515-520, 1981.
494. WEBBER, S. E., SALONEN, R. O., AND WIDDICOMBE, J. G.: Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep. Br. J. Pharmacol. 99: 21-26, 1990.
495. 1Dβ. Proc. Natl. Acad. Sci. USA 89: 3630-3634, 1992.
496. 1 receptors mediate inhibition of cyclic AMP production in neurones. Eur. J. Pharmacol. 120: 227-230, 1986.
497. 14 agonists measured with the forced swim test. Psychopharmacology 101: 497-504, 1990.
498. 4 receptor in the monkey heart. Pharmacologist 33: 218, 1991.
499. 1D subtypes. Life Sci. 45: 1433-1442, 1989.
500. 125I]Lysergic acid diethylamide binds to a novel serotonin site on rat choroid plexus epithelial cells. J. Neurosci. 5: 3178-3183, 1985.
501. 3 receptors as cation channels. In Central and Peripheral 5-HT3 Receptors, edited by M. Hamon, pp. 103-128, Academic Press, London, UK, 1992.
502. 3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line. Neuron 1: 615-621, 1988.
503. 3 receptor in NG 108-15 cells. Brain Res. 533: 46-52, 1990.
504. 3 receptor in a rat glioma X mouse neuroblastoma hybrid cell. J. Physiol. (Lond.) 436: 293-308, 1991.
505. YAKEL, J. L., TRUSSEL, L. O., AND JACKSON, M. B.: Three serotonin responses in cultured mouse hippocampal and striatal neurones. J. Neurosci. 8: 1273-1285, 1988.
506. YANG, J.: Ion permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N 18 cells. J. Gen. Physiol. 96: 1177-1198, 1990.
507. 1A receptor in rat and guinea-pig hippocampal membranes. Eur. J. Pharmacol. 137: 293-294, 1987.
508. 1C receptor contains eight hydrophobic domains and is X-linked. Mol. Brain Res. 11: 143-149, 1991.
509. 1D receptor subtype. Mol. Pharmacol. 40: 1036-1042, 1991.
510. 1Dβ receptors stably expressed in murine fibroblasts: inhibition of adenylyl cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G-protein(s). Mol. Pharmacol. 44: 575-582, 1993.
511. ZIFA, E., AND FILLION, G.: 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44: 401-458, 1992.